Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Supplemented Analgesia for Delirium in Elderly Hip Fracture Surgery
NCT04955249Phase 4Terminated
- Sponsor
- Peking University First Hospital
- Start
- Nov 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in postoperative delirium (POD), sponsored by Peking University First Hospital. Started Nov 2021; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT04955249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04955249.